Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.36.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.36.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.86.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.86.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-15341.2China
BA.2.86.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDFORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDFNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.575.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.575.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.575.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.575.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
XBB.2.3.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.620ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.620ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.620ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.620NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDMNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used